Moderna is one of three vaccine manufacturers to have reached supply deals with Switzerland.
Copyright 2020 The Associated Press. All Rights Reserved
Switzerland has increased its coronavirus vaccine order with Moderna by three million doses. This Alpine country now has 15.8 million doses of vaccines on order from three different manufacturers, pending approval from the health regulator.
This content was published on
2 minutes
swissinfo.ch/mga
The Swiss government increased its previous order with the US biotechnology company for its mRNA vaccine to a new total of 7.5 million doses, it was announced on Tuesday. Earlier this week, Switzerland added a vaccine from Pfizer/BioNTech to its desired stockpile list.
Switzerland’s membership of the World Health Organization COVAXExternal link initiative would also grant access to enough vaccines to cover 20% of the Swiss population.
Health regulator Swissmedic is currently evaluating the safety of several vaccine candidates under its “rolling procedure”, which allows manufacturers to submit the results of test studies in stages. So far, no vaccine has yet been approved.
On Wednesday, Swiss pharmaceutical giant Roche said it had reached an agreement with Moderna to extend the use of its Elecsys Anti-SARS-CoV-2 Sdiagnostic tool to speed up testing of its vaccine.
“To enhance our understanding of vaccines against SARS-CoV-2 there would be a benefit in knowing the starting levels of antibodies a person has, prior to vaccination, in order to evaluate any change in antibody levels that the vaccine induces,” Roche stated in a press release.
The Elecsys Anti-SARS-CoV-2 Sdiagnostic tool was granted emergency use authorisation by the US health authorities last month.
More
More
Coronavirus: the situation in Switzerland
This content was published on
An overview of the latest Covid-related information in the Alpine nation.
Council of Europe warns against excluding Ukraine and Europe from peace talks
This content was published on
The Secretary General of the Council of Europe, Alain Berset, has warned against the exclusion of Ukraine and Europe from peace negotiations.
Switzerland records fewer illegal medicine imports
This content was published on
Last year, the Federal Office for Customs and Border Security seized 15% fewer illegal imports of medicine than the previous year.
Swiss president reacts to US vice president’s speech in Munich
This content was published on
For Swiss President Karin Keller-Sutter, the Munich Security Conference was marked by uncertainty over the course of US foreign policy.
Swiss ‘Covid leaks’ scandal: court keeps gagging order
This content was published on
Swiss prosecutors, investigating a leak of confidential government information during Covid-19, remain blocked from seeing sensitive communication.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Incomplete data stalls Swiss authorisation of Covid-19 vaccines
This content was published on
Switzerland’s medical regulator says it lacks the necessary information to sign off on three different vaccines ordered by the government.
Switzerland secures three million doses of Pfizer/BioNTech vaccine
This content was published on
Some 4.5 million doses of another vaccine have already been agreed with United States pharma company Moderna and another 5.3 million doses from the British-Swedish firm AstraZeneca. The government said on MondayExternal link that membership of the World Health Organization COVAXExternal link initiative grants vaccine coverage to 20% of the Swiss population. The Pfizer/BioNTech vaccine would require…
This content was published on
With a death toll of over 5,000, Switzerland (population 8.5 million) expects to launch its coronavirus vaccination campaign in early January.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.